Hospital
Boston Medical Center - Brighton Corporation
Boston Medical Center - Brighton Corporation was paid $467K by Medicaid between Oct 2024 and Dec 2024, across 87 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.
33Billing provider infoBOSTON MEDICAL CENTER - BRIGHTON CORPORATION
BOSTON, MA 02135
BOSTON, MA 02135
33aNPI1720814072assigned 09/12/2024
33bProvider typeGeneral Acute Care Hospital
28Total paid$467K
24GClaims7,135
24DCodes billed87
24AFirst – last monthOct 2024 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Massachusetts
Rank by total paid#51 of 66
Median peer was paid$29.11M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 7,135 | $467K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 387 | 371 | $68K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 439 | 405 | $67K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 390 | 366 | $65K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 237 | 232 | $48K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.7% | 206 | 198 | $45K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5.0% | 108 | 100 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 85 | 58 | $18K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2.2% | 15 | 13 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 55 | 53 | $9K |
| 87428 | 1.9% | 153 | 152 | $9K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 14 | 14 | $8K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.7% | 44 | 44 | $8K |
75 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.5% | 49 | $7K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.5% | 68 | $7K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 33 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 36 | $5K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 46 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 30 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 121 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 36 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 16 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 470 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 35 | $2K |
| ATP14 | <1% | 212 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 40 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 104 | $2K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 22 | $2K |
| 88342 | <1% | 21 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 117 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 220 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 47 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 47 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 35 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 32 | $1K |
| 81513 | <1% | 13 | $1K | |
| 90688 | <1% | 52 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 145 | $962.54 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 37 | $959.14 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 88 | $858.36 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $831.54 |
| 84702 | <1% | 74 | $822.74 | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $692.95 |
| ATP08 | <1% | 71 | $618.12 | |
| 81025 | <1% | 96 | $614.79 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 235 | $599.40 |
| 84484 | <1% | 80 | $561.00 | |
| 83690 | <1% | 88 | $516.80 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 38 | $400.14 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 56 | $368.08 |
| 86850 | <1% | 41 | $318.94 | |
| 81001 | <1% | 129 | $288.40 | |
| 87481 | <1% | 13 | $278.46 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $254.88 |
| 83735 | <1% | 44 | $218.67 | |
| 87077 | <1% | 30 | $213.90 | |
| 73030 | <1% | 13 | $193.82 | |
| 87081 | <1% | 36 | $193.05 | |
| 81003 | <1% | 121 | $178.20 | |
| ATP15 | <1% | 15 | $158.76 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 37 | $152.72 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 68 | $152.72 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 154 | $143.06 |
| 85610 | <1% | 34 | $105.84 | |
| 86901 | <1% | 43 | $102.96 | |
| 86900 | <1% | 43 | $102.96 | |
| 73630 | <1% | 18 | $77.53 | |
| 73562 | <1% | 17 | $77.53 | |
| 73610 | <1% | 12 | $77.53 | |
| 85730 | <1% | 13 | $63.60 | |
| 80053 | Comprehensive metabolic panel | <1% | 272 | $57.97 |
| 82947 | <1% | 19 | $27.76 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 143 | $14.92 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 35 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 67 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 14 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 147 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 38 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 108 | $0.00 |
| 31231 | 0% | 13 | $0.00 | |
| 90657 | 0% | 36 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 70 | $0.00 |
| 80076 | 0% | 33 | $0.00 | |
| 80061 | Lipid panel | 0% | 45 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 15 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 90 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELL, ALASTAIR (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Boston Medical Center - South Corporation | Brockton, MA | $553K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.